Laser Treatment Improves Actinic Keratosis, but ‘Molecular Scar’ May Persist, Study Finds
Clinical and histological data show reduced lesions and dermal remodeling after treatment, but underlying markers of cancerization remained unchanged.
Clinical and histological data show reduced lesions and dermal remodeling after treatment, but underlying markers of cancerization remained unchanged.
The ready-to-use liquid botulinum toxin treatment requires no reconstitution. Phase III trials showed improvements in frown lines, with some patients maintaining results for up to six months.